Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 581 to 590

CHEMMART ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

3 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 80 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

3 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART ATORVASTATIN atorvastatin (as calcium propylene glycol solvate) 20 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

3 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART VALACICLOVIR valaciclovir hydrochloride monohydrate 500mg tablet blister pack Cancelled under Section 30(1) (c) of the Act

30 May 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS VALACICLOVIR valaciclovir hydrochloride monohydrate 500mg tablet blister pack Cancelled under Section 30(1) (c) of the Act

30 May 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS SUMATRIPTAN sumatriptan 50 mg (as succinate) tablet blister pack Cancelled under Section 30(1) (c) of the Act

30 May 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART SUMATRIPTAN sumatriptan 50 mg (as succinate) tablet blister pack Cancelled under Section 30(1) (c) of the Act

30 May 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART INDAPAMIDE SR indapamide hemihydrate 1.5 mg modified release tablet blister pack Cancelled under Section 30(1) (c) of the Act

30 May 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS INDAPAMIDE SR indapamide hemihydrate 1.5 mg modified release tablet blister pack Cancelled under Section 30(1) (c) of the Act

30 May 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
APREPITANT APOTEX (Apotex Pty Ltd)

30 May 2019

Prescription medicine registration

Active ingredients: aprepitant.

Pages

First page
Previous page
…
Page 55
Page 56
Page 57
Page 58
Current page 59
Page 60
Page 61
Page 62
Page 63
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.